GILD – Smarter Investing

Gilead's $12 billion takeover of Kite Pharma turns heads

Strategies

Gilead fires up biotech

The backlash against expensive medicine hurts healthcare stocks.

Strategies

Improved US earnings could push stock prices up 7% by mid-2016.

Outlook

Here are some stocks I believe will perform well over the next decade.

Strategies

Mergers are driving up biotech stocks, but beware of short traders.

Outlook

Retail, airlines and housing stocks look promising as energy prices fall.

Strategies

Taming your emotions is crucial to long-term investing success.

Strategies

This is a month that tested my investment skills.

Strategies

Rockledge Group's new sector-rotation portfolio likes healthcare.

If we see evidence of some major sectors turning to the upside, we will consider pressing more long trades in our model.

Strategies

The Net Payout Yields model gained a solid 4.9% in February versus 4.1% for the benchmark S&P 500.

Strategies

In investing, the counterpart of the gravity theory in physics is the law of mean reversion.

Strategies